Screening for Possible Drug Carcinogenicity: Second Report of Findings2
- 1 December 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 71 (6) , 1165-1175
- https://doi.org/10.1093/jnci/71.6.1165
Abstract
Cancer development was followed up through 1978 in 143,574 outpatients who were identified on the basis of computer-stored drug-dispensing data as users of various medicinal drugs during the 4-year period starting in July 1969. Screening analyses were repeated for the 95 most commonly used drugs and drug groups, which were reported previously after a shorter follow-up, and it was found that several drugcancer associations had either gained or lost statistical significance since the report. Screening of 120 additional less commonly used drugs revealed one negative and 43 positive drug-cancer associations. A few of these associations suggested interesting new hypotheses about possible drug effects, but further study is required before conclusions on causality can be drawn. The absence of association with cancer for many drugs provides some provisional assurance for the absence of carcinogenicity, but further follow-up is needed to rule out later effects.Keywords
This publication has 5 references indexed in Scilit:
- Phenylbutazone, musculoskeletal disease, and leukemiaJournal of Chronic Diseases, 1982
- Barbiturates and Lung Cancer In Humans23JNCI Journal of the National Cancer Institute, 1981
- Initial Screening for Carcinogenicity of Commonly Used Drugs23JNCI Journal of the National Cancer Institute, 1980
- INDUCTION OF SQUAMOUS-CELL CARCINOMAS OF THE RAT NASAL CAVITY BY INHALATION EXPOSURE TO FORMALDEHYDE VAPOR1980
- Monitoring Treatment Differences in Long-Term Clinical TrialsBiometrics, 1977